HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systematized epidermal nevus with epidermolytic hyperkeratosis improving with topical calcipotriol/betametasone dipropionate combination ointment.

Abstract
We present the case of a 5-year-old boy who presented with systematized epidermal nevus with evidence of epidermolytic hyperkeratosis on skin biopsy. He was otherwise well, with normal growth and development and no evidence of other organ system involvement. He had experienced only mild improvement with potent topical corticosteroids. He reported more-marked improvement after 2 months of topical calcipotriol/betamethasone dipropionate combination ointment once a day to the lesions. Extensive epidermal nevi can lead to severe cosmetic disfigurement. We recommend a trial of topical calcipotriol/betamethasone dipropionate ointment for patients with extensive epidermal nevus not amenable to surgical treatment.
AuthorsMark Jean-Aan Koh, Joyce Siong-See Lee, Wei-Sheng Chong
JournalPediatric dermatology (Pediatr Dermatol) 2013 May-Jun Vol. 30 Issue 3 Pg. 370-3 ISSN: 1525-1470 [Electronic] United States
PMID22938157 (Publication Type: Case Reports, Journal Article)
Copyright© 2012 Wiley Periodicals, Inc.
Chemical References
  • Anti-Inflammatory Agents
  • Dermatologic Agents
  • Ointments
  • calcipotriene
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • Calcitriol
Topics
  • Administration, Topical
  • Anti-Inflammatory Agents (administration & dosage)
  • Betamethasone (administration & dosage, analogs & derivatives)
  • Calcitriol (administration & dosage, analogs & derivatives)
  • Child, Preschool
  • Dermatologic Agents (administration & dosage)
  • Humans
  • Hyperkeratosis, Epidermolytic (complications, drug therapy, pathology)
  • Male
  • Nevus (complications, drug therapy, pathology)
  • Ointments (administration & dosage)
  • Skin Neoplasms (complications, drug therapy, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: